| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $918.8M | -30.1% |
| Cost of Revenue | $846.6M | -32.0% |
| Gross Profit | $72.2M | +2.9% |
| R&D Expense | $4.5M | -43.1% |
| SG&A Expense | $40.6M | -18.9% |
| Operating Income | -$46.0M | +55.9% |
| Pre-tax Income | -$62.1M | +46.9% |
| Income Tax | $31K | -81.0% |
| Net Income | -$62.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.0M | -43.4% |
| Accounts Receivable | $3.8M | -61.3% |
| Inventory | $214.2M | -22.5% |
| Current Assets | $294.2M | -20.8% |
| Total Assets | $313.1M | -17.6% |
| Current Liabilities | $251.0M | -9.1% |
| Total Liabilities | $265.4M | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $20.8M | -92.0% |
| Capital Expenditures | $5.4M | +4158.3% |
| Investing Cash Flow | -$5.3M | -368.3% |
| Financing Cash Flow | -$21.8M | +93.3% |
| Free Cash Flow | $15.4M | -94.1% |
| +47.0% |
| EPS (Basic) | -$2.27 | +48.9% |
| EPS (Diluted) | -$2.27 | +48.9% |
| Stockholders' Equity |
| $47.7M |
| -53.2% |